Über uns
Über uns
Führungsteam
Unsere Verantwortung
Kollaborationen
Unsere Standorte
Technologie
Technologie
Produktion
Publikationen
Pipeline
Newsroom
News
Events
Downloads
Investor Relations
Überblick
Analysten-Coverage
Hauptversammlung
Finanzberichte
Corporate Governance
E-Mail Alert
Karriere
Werden Sie Teil der RNA people
Ausbildung
Aktuelle Stellenangebote
DE
Antibodies
Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies
by Elena Drammis
mRNA: A novel Avenue to Antibody Therapy
by Sovereign
mRNA as novel technology for passive immunotherapy
by Sovereign
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
by Sovereign
